273 related articles for article (PubMed ID: 37420030)
1. Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy.
Gao J; Fang Y; Chen J; Tang Z; Tian M; Jiang X; Tao C; Huang R; Zhu G; Qu W; Wu X; Zhou J; Fan J; Liu W; Shi Y
Oncogene; 2023 Aug; 42(33):2507-2520. PubMed ID: 37420030
[TBL] [Abstract][Full Text] [Related]
2. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m
Xu QC; Tien YC; Shi YH; Chen S; Zhu YQ; Huang XT; Huang CS; Zhao W; Yin XY
Oncogene; 2022 Mar; 41(11):1622-1633. PubMed ID: 35094011
[TBL] [Abstract][Full Text] [Related]
3. m6A RNA methylation-mediated upregulation of HLF promotes intrahepatic cholangiocarcinoma progression by regulating the FZD4/β-catenin signaling pathway.
Xiang D; Gu M; Liu J; Dong W; Yang Z; Wang K; Fu J; Wang H
Cancer Lett; 2023 Apr; 560():216144. PubMed ID: 36958694
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 promotes intrahepatic cholangiocarcinoma progression and desensitises cisplatin treatment by increasing CDKN1B mRNA degradation.
Huang CS; Zhu YQ; Xu QC; Chen S; Huang Y; Zhao G; Ni X; Liu B; Zhao W; Yin XY
Clin Transl Med; 2022 Jun; 12(6):e848. PubMed ID: 35696608
[TBL] [Abstract][Full Text] [Related]
5. VIRMA facilitates intrahepatic cholangiocarcinoma progression through epigenetic augmentation of TMED2 and PARD3B mRNA stabilization.
Xu H; Lin X; Li Z; He X; Li Y; Qiu L; Lu L; Liu B; Zhan M; He K
J Gastroenterol; 2023 Sep; 58(9):925-944. PubMed ID: 37391589
[TBL] [Abstract][Full Text] [Related]
6. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
7. RNA N
Chen H; Gao S; Liu W; Wong CC; Wu J; Wu J; Liu D; Gou H; Kang W; Zhai J; Li C; Su H; Wang S; Soares F; Han J; He HH; Yu J
Gastroenterology; 2021 Mar; 160(4):1284-1300.e16. PubMed ID: 33217448
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma.
Yang SM; Kim J; Lee JY; Lee JS; Lee JM
BMB Rep; 2023 Nov; 56(11):600-605. PubMed ID: 37401237
[TBL] [Abstract][Full Text] [Related]
9. Aldolase A Enhances Intrahepatic Cholangiocarcinoma Proliferation and Invasion through Promoting Glycolysis.
Li X; Yu C; Luo Y; Lin J; Wang F; Sun X; Gao Y; Tan W; Xia Q; Kong X
Int J Biol Sci; 2021; 17(7):1782-1794. PubMed ID: 33994862
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA FAM66C promotes tumor progression and glycolysis in intrahepatic cholangiocarcinoma by regulating hsa-miR-23b-3p/KCND2 axis.
Lei GL; Li Z; Li YY; Hong ZX; Wang S; Bai ZF; Sun F; Yan J; Yu LX; Yang PH; Yang ZY
Environ Toxicol; 2021 Nov; 36(11):2322-2332. PubMed ID: 34418280
[TBL] [Abstract][Full Text] [Related]
11. A Novel Trojan Horse Nanotherapy Strategy Targeting the cPKM-STMN1/TGFB1 Axis for Effective Treatment of Intrahepatic Cholangiocarcinoma.
Chen ZW; Kang FP; Xie CK; Liao CY; Li G; Wu YD; Lin HY; Zhu SC; Hu JF; Lin CF; Huang Y; Tian YF; Huang L; Wang ZW; Chen S
Adv Sci (Weinh); 2023 Nov; 10(32):e2303814. PubMed ID: 37789644
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
[TBL] [Abstract][Full Text] [Related]
13. Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.
Zeng TM; Pan YF; Yuan ZG; Chen DS; Song YJ; Gao Y
Front Immunol; 2022; 13():943066. PubMed ID: 36159865
[TBL] [Abstract][Full Text] [Related]
14. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
[TBL] [Abstract][Full Text] [Related]
15. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
[TBL] [Abstract][Full Text] [Related]
16. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.
Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L
J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939
[TBL] [Abstract][Full Text] [Related]
17. METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy.
Sun Y; Shen W; Hu S; Lyu Q; Wang Q; Wei T; Zhu W; Zhang J
J Exp Clin Cancer Res; 2023 Mar; 42(1):65. PubMed ID: 36932427
[TBL] [Abstract][Full Text] [Related]
18. m
Zheng H; Zhu M; Li W; Zhou Z; Wan X
Liver Int; 2022 May; 42(5):1144-1157. PubMed ID: 35274813
[TBL] [Abstract][Full Text] [Related]
19. CCL3 secreted by hepatocytes promotes the metastasis of intrahepatic cholangiocarcinoma by VIRMA-mediated N6-methyladenosine (m
Zhou S; Yang K; Chen S; Lian G; Huang Y; Yao H; Zhao Y; Huang K; Yin D; Lin H; Li Y
J Transl Med; 2023 Jan; 21(1):43. PubMed ID: 36691046
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance and therapeutic potential of hedgehog signaling in intrahepatic cholangiocellular carcinoma.
Tang L; Tan YX; Jiang BG; Pan YF; Li SX; Yang GZ; Wang M; Wang Q; Zhang J; Zhou WP; Dong LW; Wang HY
Clin Cancer Res; 2013 Apr; 19(8):2014-24. PubMed ID: 23493353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
